Publicaciones en colaboración con investigadores/as de Instituto Universitario de Oncologia del Principado de Asturias (11)

2016

  1. Analysis of clinical prognostic variables for Chronic Lymphocytic Leukemia decision-making problems

    Journal of Biomedical Informatics, Vol. 60, pp. 342-351

  2. Drug-induced hyperploidy stimulates an antitumor NK cell response mediated by NKG2D and DNAM-1 receptors

    OncoImmunology, Vol. 5, Núm. 2

2015

  1. NKG2D signaling in cancer immunosurveillance

    International Journal of Cancer, Vol. 136, Núm. 8, pp. 1741-1750

  2. Pleiotropic anti-angiogenic and anti-oncogenic activities of the novel mithralog demycarosyl-3D-ß-D-digitoxosyl-mithramycin SK (EC-8042)

    PLoS ONE, Vol. 10, Núm. 11

2014

  1. Expansion of NK cells and reduction of NKG2D expression in chronic lymphocytic leukemia.Correlation with progressive disease

    PLoS ONE, Vol. 9, Núm. 10

  2. Molecular bases for the regulation of NKG2D ligands in cancer

    Frontiers in Immunology

2013

  1. Lenalidomide and chronic lymphocytic leukemia

    BioMed Research International, Vol. 2013

  2. Regulation of NKG2D signaling during the epithelial-to-mesenchymal transition

    OncoImmunology, Vol. 2, Núm. 9

2012

  1. Expression of ERp5 and GRP78 on the membrane of chronic lymphocytic leukemia cells: Association with soluble MICA shedding

    Cancer Immunology, Immunotherapy, Vol. 61, Núm. 8, pp. 1201-1210

  2. Patients with psoriatic arthritis may show differences in their clinical and genetic profiles depending on their age at psoriasis onset

    Clinical and Experimental Rheumatology, Vol. 30, Núm. 4, pp. 476-480

2010

  1. Prognostic significance of CD8 and CD4 T cells in chronic lymphocytic leukemia

    Leukemia and Lymphoma, Vol. 51, Núm. 10, pp. 1829-1836